Through clinical pathological analysis, we revealed that negative CPS1 expression was significantly correlated with tumor size, macrovascular invasion, Bacelona Clinic Liver Cancer (BCLC) stage and poor differentiation (Table 1). Here, CPS1 is linked to liver cancer.